Enhanced serum glucocorticoid levels mediate the reduction of serosal mast cell numbers in diabetic rats

Life Sciences

Volumn 68, Issue 26, 2001, Pages 2925-2932

  Diaz, Bruno ^a   Barreto, Emiliano ^a   Cordeiro, Renato ^a   Perretti, Mauro ^b   Martins, Marco ^a   Silva, Patrícia ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Diabetes; Glucocorticoids; Mast cells

Indexed keywords

ALLOXAN; CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ANTAGONIST; INSULIN; MIFEPRISTONE;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CELL COUNT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIABETES MELLITUS; DOWN REGULATION; DRUG INDUCED DISEASE; MALE; MAST CELL; NONHUMAN; PLEURA CAVITY; RAT; SEROSA;

ADRENALECTOMY; ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOCORTICOIDS; HYPERGLYCEMIA; INSULIN; MALE; MAST CELLS; MIFEPRISTONE; PLEURA; RATS; RATS, WISTAR;

EID: 0035906894     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01087-6     Document Type: Article

References (23)

1. Rayfield JE, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: The case for glucose control. American Journal of Medicine 1982; 72(3): 439-50.
2. Larkin JG, Frier BM, Ireland J. Diabetes mellitus and infection. Postgraduation Medical Journal 1985; 61(713): 233-7.
3. Helander E. Asthma and diabetes. Acta Medica Scandinava 1958; 162 (1): 166-74.
4. Lasser E. Asthma and diabetes mellitus: A biochemical basis for antithetical features. Medical Hypotheses 1987; 23(1): 95-106.
5. Vianna EO, Garcia-Leme J. Allergen-induced airway inflammation in rats. Role of insulin. American Journal of Respiratory and Critical Care Medicine 1995; 151 (3PT1): 809-14.
6. Diaz BL, Serra MF, Alves AC, Correa FMA Cordeiro RSB, Martins MA, Silva PMR. Alloxan diabetes reduces pleural mast cell numbers and the subsequent eosinophil influx induced by allergen in sensitized rats. International Archives of Allergy and Immunolology 1996; 111 (1):36-43.
7. Diaz BL, Serra MF, Barret EO, Cordeiro RSB, Martins Ma Silva PMR, Antigen-induced pleural eosinophilia is suppressed in diabetic rats: Role of corticosteroid hormones. Memórias do Instituto Oswaldo Cruz 1997; 92 (suppl.2):219-22.
8. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiology Review 1997; 77(4): 1033-79.
9. Pipkorn U, Hammarlund A, Enerback L. Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen-induced weal-and-flare response and a reduction in skin mast cell numbers and histamine content. Clinical Experimental Allergy 1989; 19(1): 19-25.
10. Goldsmith P, McGarity B, Walls AF, Church MK, Millward-Sadler GH, Robertson DA, Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Digestion Disease Science 1990; 35 (11):1409-13.
11. Finotto S, Mekori YA, Metcalfe DD. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: In vitro and in vivo evidence in murine systems. Journal of Clinical Investigation 1997; 99 (7):1721-28.
12. Derijk R, Sternberg EM. Corticosteroid action and neuroendocrine-immune interactions. Annals of the New York Academy of Science 1994; 746(): 33-41.
13. Garcia-Leme J, Farsky SP. Hormonal control of inflammatory responses. Mediators of Inflammation 1993, 2(3):181-98.
14. Perretti M, Flower RJ. Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry:modulation by glucocorticoids and inflammation. British Journal of Pharmacology 1996; 118(3): 605-10.
15. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. European Journal of Clinical Pharmacology 1993, 45(Suppl 1):S3-7.
16. Didonato JA, Saatcioglu F, Karin M. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. American Journal of Respiratory and Critical Care Medicine 1996; 154(2 Pt2): S11-15.
17. Flower R, Rothwell NJ. Lipocortin-1 : Cellular mechanisms and clinical relevance. Trends in Pharmacological Science 1994; 15 (3): 71-6.
18. Adamkiewski VW, Langlois Y. Canadian Journal of Biochemistry and Physiology 1957; 35(1): 251-56.
19. Strauss DS. Growth stimulatory actions of insulin in vitro and in vivo. Endocrine Review 1984; 5(2): 5 356-69.
20. Meeghan WP, Leedom.JL Henry J.P. Acta Physiologica Scandinava 1988; 571(): 117-28.
21. Ludvik B, Clodi M, Kautzky-Willer A, Capek M, Hartter E, Pacini G, Prager R. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia 1993; 36(1): 84-7.
22. Isoniemi HM, Ahonen J, Tikkanen MJ, van Willebrand EO, Krogerus L, Eklund BH, Hockerstedt KV, Salmela KE, Hayry P. Long-term consequences of different immunosuppressive regimens for renal allografts. Transplantation 1993; 55(3): 494-99.
23. Huang S-W. Asthma and diabetes. The Lancet 1999; 354(9177): 515-16.